And in many cases standard treatments with Lupron (leuprolide) or Zoladex (goserelin) is commonly not accessible and/or also high priced. Recently developed ADT treatments for instance abiraterone and enzalutamide are solely outside of arrive at economically for many African individuals and sometimes not accessible in the least in small- and lower-